ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2024

Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials.

Moeber M Mahzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.